课题基金 / 基金详情

SAFETY/EFFECACY OF INTRATRACH RH CUZNSOD TO PREVENT BPD IN PREM INFANTS W/RDS

SAFETY/EFFECACY OF INTRATRACH RH CUZNSOD TO PREVENT BPD IN PREM INFANTS W/RDS
Intratrach RH CUZNSOD 预防患有 RDS 的早产儿 BPD 的安全性/有效性
批准号:
6114985
负责人:
John Patrick Kinsella
金额:
$1.99万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

John Patrick Kinsella的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objective of this multicenter double-blind, placebo controlled randomized study is to evaluate the safety and efficacy of multiple doses of r-h CuZnSOD to prevent oxygen toxicity & severe lung disease in neonates who require mech. vent. At present there is only symptomatic tx for oxygen toxicity. Surfactant therapy improves RDS (Resp. Distress Syndrome) but not PBD (Bronchopulm. Dysp.), a chronic inflammatory condition of the lungs triggered by exposure to O2 in premature infants, who are known to have very reduced levels of antioxidant enzymes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Non-Invasive Inhaled NO in Premature Newborns
  • 批准号:
    8214143
  • 项目类别:
  • 资助金额:
    $6.49万
  • 财政年份:
    2011
  • 负责人:
    John Patrick Kinsella
  • 依托单位:
INHALED NITRIC OXIDE FOR PREVENTION OF CHRONIC LUNG DISEASE IN PREMATURE INFANTS
  • 批准号:
    7605055
  • 项目类别:
  • 资助金额:
    $5.13万
  • 财政年份:
    2007
  • 负责人:
    John Patrick Kinsella
  • 依托单位:
A 7-DAY MULTICENTER TRIAL OF IV SILDENAFIL FOR NEONATES WITH PPHN
  • 批准号:
    7374357
  • 项目类别:
  • 资助金额:
    $0.56万
  • 财政年份:
    2006
  • 负责人:
    John Patrick Kinsella
  • 依托单位:
INHALED NITRIC OXIDE FOR PREVENTION OF CHRONIC LUNG DISEASE IN PREMATURE INFANTS
  • 批准号:
    7374323
  • 项目类别:
  • 资助金额:
    $16.75万
  • 财政年份:
    2006
  • 负责人:
    John Patrick Kinsella
  • 依托单位:
海外基金